Susan L. Andersen
Laboratory for Developmental Neuropsychopharmacology
Harvard Medical School
McLean Hospital
Boston
USA
Name/email consistency: high
- Juvenile methylphenidate modulates reward-related behaviors and cerebral blood flow by decreasing cortical D3 receptors. Andersen, S.L., Napierata, L., Brenhouse, H.C., Sonntag, K.C. Eur. J. Neurosci. (2008)
- Delayed effects of early stress on hippocampal development. Andersen, S.L., Teicher, M.H. Neuropsychopharmacology (2004)
- Altering the course of neurodevelopment: a framework for understanding the enduring effects of psychotropic drugs. Andersen, S.L., Navalta, C.P. Int. J. Dev. Neurosci. (2004)
- Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Andersen, S.L., Arvanitogiannis, A., Pliakas, A.M., LeBlanc, C., Carlezon, W.A. Nat. Neurosci. (2002)
- Changes in the second messenger cyclic AMP during development may underlie motoric symptoms in attention deficit/hyperactivity disorder (ADHD). Andersen, S.L. Behav. Brain Res. (2002)
- Pubertal changes in gonadal hormones do not underlie adolescent dopamine receptor overproduction. Andersen, S.L., Thompson, A.P., Krenzel, E., Teicher, M.H. Psychoneuroendocrinology (2002)
- Maturational increases in c-fos expression in the ascending dopamine systems. Andersen, S.L., LeBlanc, C.J., Lyss, P.J. Synapse (2001)
- Sex differences in dopamine receptors and their relevance to ADHD. Andersen, S.L., Teicher, M.H. Neurosci. Biobehav. Rev (2000)
- Enduring neurochemical effects of early maternal separation on limbic structures. Andersen, S.L., Lyss, P.J., Dumont, N.L., Teicher, M.H. Ann. N. Y. Acad. Sci. (1999)